BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3660987)

  • 1. [The specific inhibitory effect of cancer serum on mouse lymphocyte SCM reaction].
    Qian XL; Zhang RD; Kong LM; Zhang HZ
    Shi Yan Sheng Wu Xue Bao; 1987 Jun; 20(2):171-7. PubMed ID: 3660987
    [No Abstract]   [Full Text] [Related]  

  • 2. Action mechanism in vitro of sensitized regional lymph node cells on target cell. II. Difference in the biological effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11 cell).
    Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):99-117. PubMed ID: 4268713
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
    Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
    Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization.
    Hodes RJ; Terry WD
    J Immunol; 1974 Jul; 113(1):39-44. PubMed ID: 4275549
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
    Belokhvostov AS; Grikurova NK
    Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of lymphocyte and macrophage from mice immunized with Ehrlich ascites tumor cells.
    Sakashita T
    Mie Med J; 1971 Jan; 20(3):227-41. PubMed ID: 5558109
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the influencing of immunologic reactions by malignant processes].
    Scheurlen PG; Pappas A
    Verh Dtsch Ges Inn Med; 1971; 77():749-52. PubMed ID: 5156058
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
    Olinescu A; Hristescu S; Mazilu E
    Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement phenomenon.
    Petrányi GG
    Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
    [No Abstract]   [Full Text] [Related]  

  • 10. Action mechanism in vitro of sensitized regional lymph node cells on target cell. I. Anti-growth effect of regional lymph node cells of Ehrlich cancer transplanted mouse and that of normal lymph node cells induced by PHA, on Ehrlich cancer cell line (JTC-11).
    Konaga E
    Acta Med Okayama (1952); 1971 Aug; 25(4):269-85. PubMed ID: 4263561
    [No Abstract]   [Full Text] [Related]  

  • 11. Antitumor resistance activation in mice: can the immunological memory cells enhance resistance?
    Kazmin SD; Todor IN; Chekhun VF
    J Exp Clin Cancer Res; 2005 Dec; 24(4):585-93. PubMed ID: 16471321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of antitumour activity of xenogeneic antiserum by normal xenogeneic spleen cells in mice.
    Dobaczewska H; Lasek W; Marczak M; Obłakowski P; Jakóbisiak M
    Folia Biol (Krakow); 1981; 29(1):77-81. PubMed ID: 7238955
    [No Abstract]   [Full Text] [Related]  

  • 13. Neem (Azadirachta indica) leaf mediated immune activation causes prophylactic growth inhibition of murine Ehrlich carcinoma and B16 melanoma.
    Baral R; Chattopadhyay U
    Int Immunopharmacol; 2004 Mar; 4(3):355-66. PubMed ID: 15037213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-lapse changes in the concomitant immunity of lymphoid cells from different regions of Ehrlich tumor-bearing mice and alterations in blastformation rate by PHA-stimulation.
    Orita K; Tomoyasu S; Kaneda S; Miwa H; Konaga E
    Acta Med Okayama (1952); 1972 Aug; 26(3):81-8. PubMed ID: 4268711
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 16. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in SCM-responses of lymphocytes in mice after implantation with Ehrlich ascites cells.
    Cercek L; Cercek B
    Eur J Cancer (1965); 1981 Feb; 17(2):167-71. PubMed ID: 7262153
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
    Zembala M; Ptak W; Hanczakowska M
    Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapeutic potential of two gallic acid derivative compounds from leaves of Casearia sylvestris Sw (Flacourtiaceae).
    Da Silva SL; Chaar Jda S; Yano T
    Eur J Pharmacol; 2009 Apr; 608(1-3):76-83. PubMed ID: 19222998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin binding to mouse blood lymphocytes during tumor growth.
    Sitdikova SM; Amandzholov BS; Kiselevskii MV; Donenko FV
    Bull Exp Biol Med; 2005 Oct; 140(4):445-8. PubMed ID: 16671577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.